Global CRO footprint Emerald Clinical operates in 40+ countries with a 800+ professional team and 70+ location network, highlighting a scalable global delivery model suitable for multinational trials and rapid site expansion in new regions.

Therapy focus breadth Core specializations in Renal, Oncology, Autoimmune, Ophthalmology, Cardiometabolic and Early Phase development indicate opportunities to cross-sell across multiple high-demand therapeutic areas and align with sponsors seeking diverse trial pipelines.

Strong recruitment edge Award for Outstanding Patient Recruitment and Engagement and a growing prominence in patient-centric trial execution suggest a competitive advantage for sponsors needing efficient enrollment and retention in complex trials.

Elite partnerships Existing collaborations with over 160 biotech firms and 15 of the world’s top 20 pharmaceutical companies position Emerald as a trusted partner for new client programs seeking established CRO relationships and robust clinical operations.

Growth signals Recent leadership addition in Oncology medical affairs and a mid-to-high revenue range (500M–1B) indicate steady growth, potential upsell into advanced analytics, real-world evidence, and expanded global site networks for ongoing or new studies.